Foley Represents TCGX as Lead Investor in $127.5M Private Placement for Adverum Biotechnologies

Foley & Larder LLP represented TCG Crossover (“TCGX”) as the lead investor in the $127.5 million private placement for Adverum Biotechnologies. Additional investors included 5AM Ventures, Commodore Capital, Frazier Life Sciences, Logos Capital, Samsara BioCapital, Venrock Healthcare Capital Partners, and Vivo Capital, as well two large investment management firms. Adverum Biotechnologies is a clinical-stage company […]

Foley Represents TCGX as Investor in $120M Private Placement for Silence Therapeutics

Foley & Larder LLP represented TCG Crossover (“TCGX”) as an investor in the $120 million private placement for Silence Therapeutics.  Additional investors included 5AM Ventures, Frazier Life Sciences, Logos Capital, Nextech Invest (on behalf of one or more funds managed by it), Redmile Group, and Vivo Capital. Silence is a UK-headquartered biotech company pioneering the […]

Foley Represents TCGX as Lead Investor in $120M Private Financing for Mineralys Therapeutics

Foley & Larder LLP recently represented TCG Crossover (“TCGX”) as a lead investor in the $120 million private financing for Mineralys Therapeutics. TCGX was joined by RA Capital Management, as well as new investors OrbiMed and Venrock Healthcare Capital Partners and several returning investors, including Samsara BioCapital. Mineralys Therapeutics is a clinical-stage biopharmaceutical company specializing […]

How Antitrust Regulators Are Affecting M&A Transactions

In a recent webinar co-hosted by 4thly and Foley & Lardner LLP, attorneys Greg Neppl, Natasha Allen and Louis Lehot engaged in a thought-provoking discussion with 4thly’s Bret Waters. Together, they discussed the complexities of the current antitrust landscape, highlighting the challenges and uncertainties faced by companies navigating the ever-shifting merger and acquisition (M&A) landscape. […]

This blog is made available by Foley & Lardner LLP (“Foley” or “the Firm”) for informational purposes only. It is not meant to convey the Firm’s legal position on behalf of any client, nor is it intended to convey specific legal advice. Any opinions expressed in this article do not necessarily reflect the views of Foley & Lardner LLP, its partners, or its clients. Accordingly, do not act upon this information without seeking counsel from a licensed attorney. This blog is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Communicating with Foley through this website by email, blog post, or otherwise, does not create an attorney-client relationship for any legal matter. Therefore, any communication or material you transmit to Foley through this blog, whether by email, blog post or any other manner, will not be treated as confidential or proprietary. The information on this blog is published “AS IS” and is not guaranteed to be complete, accurate, and or up-to-date. Foley makes no representations or warranties of any kind, express or implied, as to the operation or content of the site. Foley expressly disclaims all other guarantees, warranties, conditions and representations of any kind, either express or implied, whether arising under any statute, law, commercial use or otherwise, including implied warranties of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Foley or any of its partners, officers, employees, agents or affiliates be liable, directly or indirectly, under any theory of law (contract, tort, negligence or otherwise), to you or anyone else, for any claims, losses or damages, direct, indirect special, incidental, punitive or consequential, resulting from or occasioned by the creation, use of or reliance on this site (including information and other content) or any third party websites or the information, resources or material accessed through any such websites. In some jurisdictions, the contents of this blog may be considered Attorney Advertising. If applicable, please note that prior results do not guarantee a similar outcome.